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Abstract
Background
Climate change is likely to further worsen ozone pollution in already heavily polluted areas,
leading to increased ozone-related health burdens. However, little evidence exists in China,
the world’s largest greenhouse gas emitter and most populated country. As China is
embracing an aging population with changing population size and falling age-standardized
mortality rates, the potential impact of population change on ozone-related health burdens
is unclear. Moreover, little is known about the seasonal variation of ozone-related health burdens under climate change. We aimed to assess near-term (mid-21st century) future annual
and seasonal excess mortality from short-term exposure to ambient ozone in 104 Chinese
cities under 2 climate and emission change scenarios and 6 population change scenarios.

Methods and findings
We collected historical ambient ozone observations, population change projections, and
baseline mortality rates in 104 cities across China during April 27, 2013, to October 31, 2015
(2013–2015), which included approximately 13% of the total population of mainland China.
Using historical ozone monitoring data, we performed bias correction and spatially downscaled future ozone projections at a coarse spatial resolution (2.0˚ × 2.5˚) for the period April
27, 2053, to October 31, 2055 (2053–2055), from a global chemistry–climate model to a fine
spatial resolution (0.25˚ × 0.25˚) under 2 Intergovernmental Panel on Climate Change Representative Concentration Pathways (RCPs): RCP4.5, a moderate global warming and
emission scenario where global warming is between 1.5˚C and 2.0˚C, and RCP8.5, a high
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global warming and emission scenario where global warming exceeds 2.0˚C. We then estimated the future annual and seasonal ozone-related acute excess mortality attributable to
both climate and population changes using cause-specific, age-group-specific, and seasonspecific concentration–response functions (CRFs). We used Monte Carlo simulations to
obtain empirical confidence intervals (eCIs), quantifying the uncertainty in CRFs and the
variability across ensemble members (i.e., 3 predictions of future climate and air quality
from slightly different starting conditions) of the global model. Estimates of future changes in
annual ozone-related mortality are sensitive to the choice of global warming and emission
scenario, decreasing under RCP4.5 (−24.0%) due to declining ozone precursor emissions
but increasing under RCP8.5 (10.7%) due to warming climate in 2053–2055 relative to
2013–2015. Higher ambient ozone occurs under the high global warming and emission scenario (RCP8.5), leading to an excess 1,476 (95% eCI: 898 to 2,977) non-accidental deaths
per year in 2053–2055 relative to 2013–2015. Future ozone-related acute excess mortality
from cardiovascular diseases was 5–8 times greater than that from respiratory diseases.
Ozone concentrations increase by 15.1 parts per billion (10−9) in colder months (November
to April), contributing to a net yearly increase of 22.3% (95% eCI: 7.7% to 35.4%) in ozonerelated mortality under RCP8.5. An aging population, with the proportion of the population
aged 65 years and above increased from 8% in 2010 to 24%–33% in 2050, will substantially
amplify future ozone-related mortality, leading to a net increase of 23,838 to 78,560 deaths
(110% to 363%). Our analysis was mainly limited by using a single global chemistry–climate
model and the statistical downscaling approach to project ozone changes under climate
change.

Competing interests: The authors have declared
that no competing interests exist.

Conclusions

MortCast Package (https://cran.r-project.org/web/
packages/MortCast/index.html). Data on
projections of city-level ozone concentrations,
population, and ozone-related excess mortality can
be accessed by contacting the Environmental
Policy and Health Risk Group, School of the
Environment, Nanjing University. Contact Email:
zma@nju.edu.cn.

Abbreviations: CRF, concentration–response
function; eCI, empirical confidence interval; GFDLCM3, Geophysical Fluid Dynamics Laboratory
chemistry–climate model CM3; MDA8, maximum
daily 8-hour average; NOx, nitrogen oxide(s); ppb,
parts per billion; PI, probability interval; RCP,
Representative Concentration Pathway; SSP,
shared socioeconomic pathway.

Our analysis shows increased future ozone-related acute excess mortality under the high
global warming and emission scenario RCP8.5 for an aging population in China. Comparison with the lower global warming and emission scenario RCP4.5 suggests that climate
change mitigation measures are needed to prevent a rising health burden from exposure to
ambient ozone pollution in China.

Author summary
Why was this study done?
• Climate change is likely to increase ozone-attributed health burdens, which are not well
understood in China, the world’s largest greenhouse gas emitter, with a rapidly aging
population.
• Few published studies have jointly evaluated future ozone-related mortality considering
changes in climate, population size, population aging, and age-group-specific mortality
rates.
• Prior research has mainly investigated summertime ozone, but little is known about the
potential seasonal variations of ozone-related acute excess mortality under climate
change.
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What did the researchers do and find?
• We used a global chemistry–climate model and recently available ambient ozone monitoring data to show future changes in ozone-related acute excess mortality from 2013–
2015 to 2053–2055 under different climate and population change scenarios in 104 cities
across China.
• We show that global climate change, particularly rising methane, leads to a 10.7% increase
in annual ozone-related non-accidental deaths under a high global warming and emission
scenario but a 24.0% decrease under a lower global warming and emission scenario.
• Although population size is expected to decline and age-group-specific mortality rates
are expected to decrease, population aging offsets these decreases and yields 1–4 times
greater ozone-related mortality under climate change in 2053–2055 than that in 2013–
2015.
• Ozone concentration increases in the cold season (November to April) under a high
global warming and emission scenario, leading to a net increase of ozone-related mortality in 2053–2055.

What do these findings mean?
• To our knowledge, this is the first study to quantify the amplifying effect of population
aging on ozone-related mortality under alternative scenarios of climate and population
change while accounting for decreases in population size and age-group-specific mortality rates.
• Cold season ozone may play a more important role than currently recognized in future
ozone-related mortality burden attributable to climate change, and future studies on
seasonal patterns are warranted.
• This study suggests that the ozone-related mortality burden in China will rise under a
high global warming and emission scenario of climate change, and mitigation measures
are needed to reduce the associated health burden.

Introduction
Climate change threatens human health via multiple pathways, including both direct impacts
from changes in temperature, precipitation, and frequency of extreme weather and indirect
impacts mediated through both natural systems (e.g., air quality and disease vectors) and
human systems (e.g., undernutrition and mental stress) [1]. Climate change is expected to
worsen ozone pollution in already heavily polluted areas through meteorological conditions
conductive to the accumulation of air pollution and weather-sensitive natural and anthropogenic emissions of ozone precursors (e.g., more emissions owing to increased air conditioning
usage in a warmer climate) [2–6]. Global and regional health impact assessments have found
adverse impacts of climate change on ozone-related health burdens [7–17]. However, most of
the regional studies have focused on developed countries [7–14], while few studies exist in the
largest developing country—China [16,17]. In addition, previous studies applied coarse-scale
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ozone projections in China [16,17], which may bias ozone-related acute excess mortality in
populous urban areas. Punger and West found that using coarse resolutions may lead to a
small overestimation (<6%) in the US [18], whereas Fenech et al. found low but significant
biases (−0.9% to +2.6%) in the attributable fraction of total mortality due to warm season
ozone exposure in Europe [19]. As China is the world’s largest emitter of greenhouse gases
[20], and suffers from severe ambient ozone pollution [21], estimating the impact of climate
change on ozone-related health effects is critical for understanding the indirect health impacts
of climate change in China.
Future ozone-related health burdens will reflect both the impact of changing ozone concentrations and changes in the size and age distribution of the exposed population. Previous studies on ozone-related health impacts under climate change have been limited by only
considering changes in population size [9–11,13,14,17], neglecting changes in population
aging. This may underestimate the influence of population change since older people are more
vulnerable to short-term ozone exposure [22] and have substantially higher baseline mortality
rates than younger people [23]. As the age-standardized death rate has been decreasing in
China [24], it remains unclear the extent to which population aging may offset the decrease in
future ozone-related acute excess mortality due to reduction in the age-standardized death
rate.
Little is known about the seasonal variation of ozone-related health burdens under climate
change. Most previous studies only projected ozone-related acute excess mortality in the warm
season, resulting in an incomplete understanding of the ozone-related acute excess mortality
across the year [3,25]. Rising ozone in the non-warm season would also pose risks since epidemiological evidence generally indicates a no-threshold concentration–response relationship
between short-term ozone exposure and mortality [26,27]. Moreover, the seasonal cycle of
ambient ozone at northern mid-latitudes has already shifted from a summer maximum to a
maximum earlier in the year during recent decades [28]. The high-ozone season may continue
to shift towards spring and winter under climate and emission changes [29], and the differences in ozone levels between the warm season and the cold season may diminish in the future
[30].
In this study, we aimed to estimate near-term future (mid-21st century) changes in annual
and seasonal ozone-related acute excess mortality in China attributable to climate and emission change and population change, based on ozone projections from a global chemistry–climate model statistically downscaled to a fine spatial resolution (0.25˚ × 0.25˚) using recently
available ambient ozone monitoring data from across China. We estimated the near-term
future changes because of their importance to decision makers in government and industry
for acting on mitigation and adaptation to reduce the health impacts of climate change. We
used 3 ensemble members from the coupled chemistry–climate model in each of 2 climate and
emission change scenarios and 6 population scenarios to account for potential uncertainties in
climate models, greenhouse gas and pollution emission projections, and population change
models [10,23,25].

Methods
This analysis was conducted in 104 Chinese cities (Fig 1A) where historical ozone concentrations, future ozone projections, population change projections, and baseline daily mortality
counts were available. These 104 cities are distributed over 29 of the 31 mainland provincial
administrative regions and included a total of 170 million people in 2010, accounting for
approximately 13% of the total population of mainland China.
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Fig 1. Historical and future changes in ambient ozone concentration and population. (A) Spatial distribution of annual average daily ozone concentration (parts per
billion [ppb]) during 2013–2015 (historical period) in 104 Chinese cities. Ozone concentration is the maximum daily 8-hour average. (B) Historical (2013–2015) and
projected (2053–2055) annual average daily ozone concentration (ppb) in 104 Chinese cities under the RCP4.5 and RCP8.5 scenarios. RCP4.5 and RCP8.5 represent
moderate and high global warming and emission scenarios, respectively. The horizontal line within each box represents the median concentration among 104 cities, the
lower and upper boundaries of the box indicate the 25th and 75th percentiles, and the ends of the whisker lines indicate the maximum and minimum concentrations
within 1.5 times the interquartile range from the upper and lower box boundaries. (C) Projected population size in 104 Chinese cities from 2010 to 2050 under 6
population change scenarios under different shared socioeconomic pathways (SSPs). (D) Projected population aging in China from 2010 to 2050 under 5 SSP
population change scenarios.
https://doi.org/10.1371/journal.pmed.1002598.g001

Historical ozone observations
Ambient ozone observations were obtained from the China National Environmental Monitoring Center (http://106.37.208.233:20035). Since ozone was not nationally monitored in China
before 2013 and air quality data were publicly available only after 2013, a total of 918 days
from April 27, 2013, to October 31, 2015, were chosen to represent the historical period. Correspondingly, the period April 27, 2053, to October 31, 2055, was used to represent the future
period. There were 778 national air quality monitoring sites (S1 Fig) involved in this study to
compute the historical ozone concentrations and to statistically downscale the future ozone
projections. Maximum daily 8-hour average (MDA8) ozone concentrations for each site were
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calculated from the hourly concentrations for days with at least 75% available values within the
day. The MDA8 metric was applied in this study as it reflects more biologically relevant exposure time within a day than the daily 24-hour average metric [31]. During our study period,
the 104 Chinese cities had an average of 10.6% of days with missing MDA8 ozone observations. Missing data were not imputed.

Future ozone projections
We analyzed global ozone simulations performed with the Geophysical Fluid Dynamics Laboratory chemistry–climate model CM3 (GFDL-CM3), which were conducted under the Coupled Model Intercomparison Project Phase 5 (CMIP5), in support of the Intergovernmental
Panel on Climate Change Fifth Assessment Report [32]. GFDL-CM3 is a coupled global-scale
physical climate model with a comprehensive treatment of interactive tropospheric and stratospheric chemistry, as well as aerosol–cloud interactions and chemistry–climate interactions
[33]. GFDL-CM3 has a native c48 cubed sphere horizontal resolution, regridded to 2.0˚ × 2.5˚
(latitude × longitude) for our analysis, and includes 48 vertical layers corresponding to the
hybrid sigma-pressure levels extending from the surface to about 80 km altitude [33]. A
detailed description of the gas-phase chemistry, historical and projected anthropogenic emissions, and lower chemical boundary conditions can be found in Naik et al. [34].
The Representative Concentration Pathway (RCP) scenarios RCP4.5 and RCP8.5 were used
to evaluate the future global change, from both well-mixed greenhouse gases and emissions of
air pollutants and their precursors, in ozone concentrations, representing moderate and high
global warming and emission scenarios, respectively [35,36]. RCP8.5 is a high greenhouse gas
emission scenario of without any mitigation [36], whereas RCP4.5 corresponds to a moderate
emission scenario [35]. By the end of the 21st century, global warming is likely to exceed 2˚C
under RCP8.5 and to be between 1.5˚C and 2.0˚C under RCP4.5 [37]. For each scenario, 3
ensemble members (i.e., 3 predictions of future climate and air quality from slightly different
starting conditions) provide some measure of unforced internal variability induced by the chaotic climate system [38]. The analysis of these 2 RCP scenarios enables us to evaluate changes
in future ozone air quality in China due to the combined changes in emissions and climate.
Compared with observations, daily GFDL-CM3 simulations overestimated ozone concentrations in the historical period by an average of +17 ppb (36%) across ensemble members. We
used a bias-correction spatial disaggregation (BCSD) method to downscale the GFDL-CM3
simulations to a high spatial resolution of 0.25˚ × 0.25˚ (approximately 25 km × 25 km).
Briefly, in the bias-correction step, we first compared the daily GFDL-CM3 simulations with
corresponding daily ozone observations within each coarse-scale grid cell (2.0˚ × 2.5˚) and
each month to identify the monthly bias at each quantile in the historical simulations relative
to observations. We matched the historical simulations and observations within the same
month rather than on the same day to obtain the historical monthly biases. We then corrected
model estimates in the future periods, assuming that historical monthly biases persist in the
future. We further downscaled the bias-corrected projections to the high spatial resolution
(0.25˚ × 0.25˚) using a spatial disaggregation method. In short, we spatially translated the biascorrected future model simulations from the coarse scale (2.0˚ × 2.5˚) to the fine scale (0.25˚ ×
0.25˚). Using the spatial distribution of monthly mean ozone observations as a spatial guide,
we first subtracted the coarse-scale spatial distribution of observations from coarse-scale biascorrected projections to get temporal scaling factors. Then we added the fine-scale spatial distribution of observations back to the fine-scale temporal scaling factors that were interpolated
using a bilinear interpolation method. See S1 Method for further details. We computed city-
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level ozone projections, as well as historical observations, by taking the weighted mean MDA8
ozone concentrations of each grid cell that fell within a certain city boundary.

Population change projections
To explore the sensitivity of ozone-related acute excess mortality estimates to assumptions
about population change, 6 population scenarios were applied in this analysis: a no population
change scenario assuming that the Chinese population remains the same from 2010 to 2050,
and 5 population projections under the shared socioeconomic pathways (SSPs) in China. For
the former, city-level population data were collected from the 2010 Population Census of
China. The latter 5 scenarios are drawn from the SSPs, which describe a set of plausible alternative futures of societal development without considering the effects of climate change and
new climate policies over the 21st century [39,40]. It is possible to combine SSPs with different
RCPs to generate a set of future scenarios that represent different levels of socioeconomic
development and climate change [41]. For China, the demographic assumptions of the 5 SSPs
are as follows: SSP1 assumes low fertility, low mortality, medium migration, high education,
and fast urbanization; SSP2 assumes medium fertility, medium mortality, medium migration,
medium education, and central urbanization (i.e., the mean urbanization growth rate of historical experience for a certain country); SSP3 assumes high fertility, high mortality, low
migration, low education, and slow urbanization; SSP4 assumes high fertility, high mortality,
medium migration, polarized education (i.e., a certain group with very high education and
large groups with low education), and fast urbanization; and SSP5 assumes low fertility, low
mortality, high migration, high education, and fast urbanization [42,43].
Chinese population size projections between 2010 and 2050 for all ages under the 5 SSPs at
0.125˚ × 0.125˚ resolution were extracted from the global projections [44]. City-level population projections were then calculated by summing the populations of each grid cell that fell
within a certain city boundary. Chinese population age structure changes between 2010 and
2050 under the 5 SSPs were obtained from the SSP Database (https://tntcat.iiasa.ac.at/SspDb).

Ozone–mortality concentration–response functions (CRFs) and baseline
mortality
Because China has higher air pollution levels and may also differ in terms of age structure,
population sensitivity to air pollution, and components of air pollution mixture compared to
developed countries [45], we used China-specific ozone CRFs in the present study. Accordingly, we applied pooled estimates of the association between short-term exposure to MDA8
ozone and daily mortality from a recent nationwide study in 272 Chinese cities [46] (Table 1).
The nationwide time-series study was conducted between 2013 and 2015, during which daily
air pollution concentrations and mortality counts were collected by the China National Environmental Monitoring Center and the China Disease Surveillance Points system, respectively
[46]. In that study, a 2-stage approach was used to obtain national average associations
between ozone concentration and cause-specific (cardiovascular, respiratory, or other), agegroup-specific (5–64 years, 65–74 years, and 75 years), and seasonal mortality for all nonaccidental deaths. Briefly, generalized linear models were first applied to estimate the acute
ozone effects on mortality in each city, and then hierarchical Bayesian models were used to
pool the city-specific estimates. Daily deaths for children under 5 years were too few and thus
were excluded in that nationwide time-series study [46]. Since the number of city-level daily
non-accidental deaths for individuals aged 5–64 years was small (Table 1), no further divisions
of this age group were applied [46]. No threshold below which no adverse health effects occur
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Table 1. Ozone–mortality concentration–response functions (CRFs) and summary statistics of daily mortality in 104 Chinese cities during 2013–2015.
Mortality

CRFa

Number of deaths
Mean ± SD

Minimum

Median

Maximum

Cause of death
All non-accidental causes

0.24 (0.13, 0.35)

23 ± 23

3

18

165

Cardiovascular

0.27 (0.10, 0.44)

11 ± 10

1

9

65

Respiratory

0.18 (−0.11, 0.47)

3±4

0

2

34

Age-group-specific non-accidental deaths
5–64 years

0.13 (−0.23, 0.48)

5±5

1

4

43

65–74 years

0.19 (0.03, 0.34)

5±5

1

4

37

75 years

0.42 (0.21, 0.64)

13 ± 13

1

9

84

Warm (May–Oct)

0.20 (0.08, 0.31)

21 ± 21

3

15

155

Cold (Nov–Apr)

0.43 (0.21, 0.65)

20 ± 17

3

16

118

Seasonal non-accidental deaths

a

3

CRFs are expressed as the percentage increase (95% confidence interval) in daily mortality associated with a 10-μg/m (approximately 5 parts per billion) increase of

maximum daily 8-hour average ozone exposure on the current day and previous 3 days. CRFs were obtained from a previous nationwide time-series study in 272
Chinese cities [46].
https://doi.org/10.1371/journal.pmed.1002598.t001

was assumed for the CRFs, as there is no evidence that supports a threshold in the relationship
between short-term ozone exposure and mortality [27,47,48].
City-level baseline cause-specific, age-group-specific, and seasonal mortality counts were
also obtained from the previous publication [46]. Future changes in age-group-specific mortality rates and their 95% probability intervals (PIs) in 2050–2055 versus 2010–2015 were
obtained using data from the United Nation’s 2017 World Population Prospects [49] and the
MortCast package, which projects age-specific mortality rates using the Kannisto, Lee–Carter,
and related methods as described in Ševčı́ková et al. [50]. The calculated changing ratios of
mortality rates in 2050–2055 versus 2010–2015 in China were 0.68 (95% PI: 0.35–1.02) for
individuals aged 5–64 years, 0.50 (95% PI: 0.26–0.73) for individuals aged 65–74 years, and
0.83 (95% PI: 0.61–1.05) for individuals aged 75 years. Because no projection data for citylevel cause-specific and seasonal mortality rates were available in China, we assumed constant
daily mortality counts for each city in the future when estimating future cause-specific and seasonal ozone-related acute excess mortality.

Health impact assessment
We used the attributable fraction (AF) method to estimate the daily ozone-related acute excess
mortality in 2013–2015 and 2053–2055, respectively. The AF is the fraction of baseline mortality attributable to ozone exposure, which is defined as [13,51]
AF ¼ 1

exp

bC

ð1Þ

where β is the coefficient of the CRF for ozone and C is the city-level daily ozone concentration
(ppb) in each period. The city-level attributable daily deaths (ADD) for ozone exposure in
each period was then calculated as follows:
ADD ¼ Yb  POP  AF ¼ Yb  POP  ð1

e

bC

Þ

ð2Þ

where ADD represents the estimated city-level number of daily deaths attributable to ozone
exposure in each period, Yb is the city-level baseline daily mortality rate, and POP is the citylevel annual population in each period (i.e., population in 2010 for the historical period and
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population in 2050 for the future period). We then calculated the annual attributable deaths by
summing ADD throughout the year. Finally, we estimated the effects of changes in ozone concentrations on mortality for each city by computing the changes in future annual attributable
deaths in 2053–2055 relative to the historical annual attributable deaths in 2013–2015 (excess
mortality).
We calculated the cause-specific, age-group-specific, and season-specific ozone-related
acute excess mortality separately by applying corresponding CRFs and baseline mortality. We
computed the GFDL-CM3 ensemble-averaged total excess mortality in 104 cities by combinations of RCPs and population scenarios. We used Monte Carlo simulations to quantify the
uncertainty in our mortality estimates by incorporating uncertainty from coefficients of CRFs
and model variability across 3 ensemble members of GFDL-CM3. We obtained the empirical
confidence intervals (eCIs) from the empirical distribution across 1,000 coefficient samples
and 3 ensemble members, assuming normal distributions for the estimated cause-specific, agegroup-specific, and season-specific coefficients, respectively. When estimating future ozonerelated acute excess mortality under population aging scenarios, we further incorporated the
uncertainty from age-group-specific mortality rate changes in the Monte Carlo simulations by
assuming normal distributions for the age-group-specific changes in total mortality rate separately. We did not include uncertainty associated with population projections in mortality estimates, because these are not reported in SSP population projections and our goal was
scenario-based projections for understanding the implications of health consequences under
future demographic and climatic conditions. To evaluate the influence of the fine-scale ozone
projections on health impact assessments, we conducted a sensitivity analysis by directly using
the coarse-scale bias-corrected ozone projections to estimate future ozone-related cause-specific excess mortality under a no population change scenario.
Four factors—ozone concentration changes due to climate and emission change, population size changes, population aging, and age-group-specific mortality rate changes—contribute
to the total future ozone-related acute excess mortality. To decompose changes in ozonerelated acute excess mortality, we estimated the contribution from each factor incrementally
for the population aged 5 years and above with age-group-specific risk estimates. We calculated the effect due to climate and emission change by applying the no population change scenario, the effect due to population size by subtracting the climate and emission change effect
from the effect when applying the population size changes under the 5 SSPs, the effect due to
population aging by subtracting the effect when applying the population size changes from the
effect when applying the population changes in both size and age structure under the 5 SSPs,
and the effect due to age-group-specific mortality rate by subtracting the effect when applying
population changes in size and age structure from the effect when applying both population
changes in size and age structure and age-group-specific mortality rate changes.

Results
Historical and future ozone concentrations
During 2013–2015, the mean annual average of observed ozone concentrations in 104 Chinese
cities was 41.6 ppb, with higher ozone concentrations observed in cities located along the east
coast of China (Fig 1A). Ensemble mean projected changes in ozone in 2053–2055 relative to
2013–2015 differed by RCP (Fig 1B). Under the moderate climate and emission change scenario, RCP4.5, the mean annual average ozone concentration declined to 32.3 ppb in 2053–
5055 relative to 2013–2015, reflecting reduction of O3 precursor emissions (S2 Fig). Under the
high climate and emission change scenario, RCP8.5, the mean annual average ozone concentration increased to 46.9 ppb in 2053–5055 relative to 2013–2015. Of all days in the historical
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period, an average of 39.0% had ozone levels exceeding the WHO air quality guidelines
(100 μg/m3, roughly equivalent to 50 ppb). In 2053–2055, the percentage of days with ozone
concentrations exceeding the air quality guidelines declined to 10.0% under RCP4.5 but
increased to 42.2% under RCP8.5. City-specific estimates of ozone changes indicated spatial
heterogeneity, with larger decreases in southern cities under RCP4.5 and larger increases in
northern cities under RCP8.5 (S3 Fig).

Population size changes and population aging
Under the SSPs, population size in 104 Chinese cities would first increase from 2010 to 2030,
then decrease from 2030 to 2050 (Fig 1C). The decrease in total population in 104 Chinese cities in 2050 relative to 2010 would range from −0.5% under SSP3 to −5.6% under SSP4. All the
SSPs projected an aging Chinese population (Fig 1D). Compared with 2010, the proportions of
the population aged between 65 and 74 years and 75 years and above in 2050 increased from
5.2% to 11.7%–14.0% and from 3.0% to 12.0%–19.0%, respectively.

Ozone-related acute excess mortality under global climate and emission
change
In the historical period, short-term exposure to ambient ozone contributed to a total of 13,856
non-accidental deaths annually in 104 Chinese cities. Historical ozone-related acute excess
mortality varied substantially among cities, with the smallest attributable deaths in Haikou
(15) and the largest attributable deaths in Nantong (820) (Fig 2A). Fig 2B shows that under a
no population change scenario, decreasing mortality impacts in 2053–2055 relative to 2013–
2015 under RCP4.5 occurred in most cities, with the largest decreases in southern cities.
Under RCP8.5, larger increases in mortality occurred in northern cities whereas smaller
increases or even decreases occurred in southern cities (Fig 2C). These spatial differences in
ozone-related acute excess mortality reflected the spatial heterogeneity of future ozone changes
under climate and emission change (S3 Fig). Relative to the historical period, annual ozonerelated non-accidental mortality in 2053–2055 decreased by −3,332 (95% eCI: −5,877 to
−2,191) deaths (−24.0%) under RCP4.5, but increased by 1,476 (95% eCI: 898 to 2,977) deaths
(10.7%) under RCP8.5 (Table 2 and Fig 2D). Mortality from cardiovascular disease accounted
for more than half of ozone-related excess deaths from global change (50.6% under RCP4.5
and 60.1% under RCP8.5), whereas mortality from respiratory disease accounted for only
10.7% under RCP4.5 and 6.9% under RCP8.5.
Using the coarse-scale (2.0˚ × 2.5˚) ozone projections yielded larger ozone concentration
changes in the future period, with an average of +1.3 ppb under RCP4.5 and +1.4 ppb under
RCP8.5 in 104 Chinese cities (S4 Fig). Compared with using the fine-scale (0.25˚ × 0.25˚)
ozone projections, ozone-related acute excess mortality estimates were +36.6% greater under
RCP8.5 and −16.3% smaller under RCP4.5. Biases due to coarse resolution presented large spatial variations across the 104 cities. These findings suggest that the ozone-related acute excess
mortality in the 104 Chinese cities was sensitive to the spatial resolution of the ozone
projections.

Ozone-related acute excess mortality under both climate and population
change
Using age-group-specific CRFs and baseline mortality yielded a larger ozone-attributed death
burden (21,592) than using all-age CRFs and baseline mortality (13,856) in the historical
period. Higher estimates of annual ozone-related acute excess mortality were observed when
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Fig 2. Impact of climate and emission change on ozone-related acute excess mortality. (A) Spatial distribution of historical annual ozone-related mortality in 104
Chinese cities during 2013–2015. (B) Spatial distribution of future changes (%) in annual ozone-related mortality under the RCP4.5 scenario in 104 Chinese cities
during 2053–2055 relative to the historical period 2013–2015. (C) Same as (B) but under RCP8.5. (D) Future changes (%) in ozone-related mortality by cause of death
(cardiovascular, respiratory, and other causes of non-accidental deaths) under RCP4.5 and RCP8.5. RCP4.5 and RCP8.5 represent moderate and high global warming
and emission scenarios, respectively.
https://doi.org/10.1371/journal.pmed.1002598.g002

the population changed in both size and age structure under the 5 SSPs (Table 2). The evolving
patterns of future ozone-related acute excess mortality under climate change differed in the 5
SSPs. The highest estimates were found using the SSP1 population scenario, whereas the lowest
estimates were observed using the SSP3 population scenario.
The evolving patterns of future ozone-related acute excess mortality reflected the influence
not only of climate and emission change, but also of changes in population size, aging, and
age-group-specific mortality rates. Fig 3 shows the contributions of these 4 factors to changes
in ozone-related mortality from 2013–2015 to 2053–2055. Decreasing excess deaths owing to
acute ozone exposure under RCP4.5 and age-group-specific mortality rate reductions were offset by population aging. Population size slightly declined in 2050 compared with 2010 (−5.6%
to −0.5%), whereas the proportion of older people between 65 and 74 years and 75 years and
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Table 2. Ensemble mean changes of annual ozone-related mortality in 104 Chinese cities in 2053–2055 relative to 2013–2015 under different climate and population scenarios.
Population

Population
scenario

Baseline mortality rate

Cause of death

RCP4.5

RCP8.5

All agesa

No change

No change

All non-accidental
causes

−3,332 (−5,877,
−2,191)

1,476 (898, 2,977)

Cardiovascular

−1,687 (−3,370, −776) 888 (404, 1,925)

Respiratory

−357 (−1,138, 308)

101 (−75, 380)

All non-accidental
causes

47,804 (20,602,
80,463)

78,560 (35,611,
131,541)

SSP2

All non-accidental
causes

35,004 (14,606,
60,544)

60,140 (26,299,
99,484)

SSP3

All non-accidental
causes

23,838 (8,609, 43,114) 44,063 (18,530,
73,377)

SSP4

All non-accidental
causes

36,357 (15,368,
63,214)

62,049 (27,497,
10,2124)

SSP5

All non-accidental
causes

47,765 (19,933,
80,981)

78,505 (34,083,
129,084)

Population aged 5 years and
aboveb

SSP1

Age-group-specific mortality
changes

Mean change in mortality (95% empirical CI)
by climate and emission change scenario

a

For the population including all ages, the calculation was based on the risk estimate of ozone-related mortality and annual baseline mortality for the whole population.

b

For the population aged 5 years and above, the calculation was based on the risk estimates of ozone-related mortality and annual baseline mortality for the population

age groups 5–64, 65–74, and 75+ years.
https://doi.org/10.1371/journal.pmed.1002598.t002

above increased by 2–3 and 4–6 times from 2010 to 2050, respectively. Since the baseline mortality and CRFs for older people aged 75 years and above are 2.6 and 3.2 times greater, respectively, than for young people aged 5–64 years (Table 1), population aging alone results in 2–5
times greater ozone-related acute excess mortality under climate change (Fig 3). This large
increase due to population aging fully offsets the decreases due to decreasing age-group-specific mortality rates (−111% to −53%). Consequently, net increases (110% to 221%) were
noted under RCP4.5 for the 5 SSP population scenarios. Under RCP8.5, increases in ozone
exposure from global climate and emission change combined with increases in population
aging resulted in large net increases in ozone-related acute excess mortality (204% to 363%).
Increases in population aging offset reductions in population size and age-group-specific mortality rates and dominated the net increases under RCP8.5.

Seasonal variation of future ozone concentration and ozone-related acute
excess mortality
Seasonal ozone changes projected under both RCPs are reported in Fig 4A. Larger reductions
in ozone concentrations were observed in the warm season (−16.6 ppb) than in the cold season
(−1.7 ppb) under RCP4.5. An opposite pattern of attenuation in the warm season (−4.2 ppb)
and a rise in the cold season (15.1 ppb) was noted under RCP8.5. Consequently, under
RCP8.5, more ozone-related acute excess mortality was projected to occur in 2053–2055 in the
cold season, whereas less warm season excess mortality was projected compared to 2013–2015.
Under RCP8.5, increased ozone-related mortality in the cold season offset reductions in the
warm season, leading to a net increase (22.3% [95% eCI: 7.7% to 35.4%]). In contrast, under
RCP4.5, ozone-related acute excess mortality was projected to experience a net decrease
(−19.5% [95% eCI: −24.8% to −12.2%]), which was mainly driven by the large reduction in
warm season impacts. The seasonal estimates of ozone-related acute excess mortality remained
similar when we considered population size changes under the 5 SSPs.
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Fig 3. Changes in ozone-related mortality according to climate and population changes from 2013–2015 to 2053–2055. Population changes include both
population size changes and population aging. Mortality rate indicates age-group-specific baseline mortality rate changes. Future changes (%) of annual ozone-related
mortality for the population aged 5 years and above in 2053–2055 were calculated relative to the historical period 2013–2015. RCP4.5 and RCP8.5 represent moderate
and high global warming and emission scenarios, respectively. SSP1–5 represent 5 population change scenarios under different shared socioeconomic pathways.
https://doi.org/10.1371/journal.pmed.1002598.g003

Discussion
In this study, we projected future ozone-related acute excess mortality in 104 Chinese cities
using statistically downscaled ozone projections at a fine spatial resolution (0.25˚ × 0.25˚).
Future changes in ozone concentration and related non-accidental deaths from 2013–2015 to
2053–2055 exhibited different patterns in China under RCP4.5 and RCP8.5. Due to the impact
of global climate and emission change, an increase in ozone-related deaths was estimated
under RCP8.5, whereas a decrease was noted under RCP4.5. Cardiovascular mortality
accounted for more than half of the mortality impacts from global climate and emission
change. Population aging will likely amplify the ozone-related acute excess mortality burden
under both RCPs. Furthermore, under RCP8.5, increased ozone concentrations (+15.1 ppb) in
colder months (November to April) will lead to more ozone-related deaths (28.1%) than those
avoided (−5.9%) due to decreased ozone concentrations (−4.2 ppb) in warmer months. Thus,
deteriorating ozone air quality in colder months will make a growing contribution to the
adverse health impacts of climate change in China.
Our estimates for projected changes in annual average ozone concentration in 104 Chinese
cities from 2013–2015 to 2053–2055 (−9.3 ppb under RCP4.5 and +5.3 ppb under RCP8.5) are
broadly consistent with recent modeling studies based on the latest RCP scenarios, which
reported a decreasing ozone concentration for RCP4.5 (around −7 to −6 ppb) and an increasing concentration for RCP8.5 (0–3 ppb) in China over 2000–2050 [52,53]. The decline of
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Fig 4. Seasonal changes in future ozone concentration and ozone-related mortality under climate and emission changes and population size changes. (A) Future
changes in annual average daily ozone concentrations (parts per billion [ppb]) during the whole year, the warm season (May–October), and the cold season
(November–April) in 2053–2055 relative to 2013–2015. RCP4.5 and RCP8.5 represent moderate and high global warming and emission scenarios, respectively. The
horizontal line within each box represents the median change in ozone concentration among 104 cities, the lower and upper boundaries of the box indicate the 25th and
75th percentiles, and the ends of the whisker lines indicate the maximum and minimum concentrations within 1.5 times the interquartile range from the upper and
lower box boundaries. (B) Future changes (%) in annual ozone-related mortality during the warm season and the cold season in 2053–2055 relative to 2013–2015.
Population size scenarios include a no change scenario and 5 population change scenarios under shared socioeconomic pathways (SSPs). Vertical lines denote 95%
empirical CIs of net change.
https://doi.org/10.1371/journal.pmed.1002598.g004
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ozone concentrations under RCP4.5 is mainly due to the assumed large reductions in emissions of ozone precursors such as nitrogen oxides (NOx) and nonmethane volatile organic
compounds (S2 Fig). Very few studies have evaluated future changes in ozone-related acute
excess mortality under climate change in China [15–17]. It is difficult to make direct comparisons between estimates from this study and previous studies, as different climate and emission
change scenarios, model simulations, baseline times, ozone metrics, causes of mortality, population size scenarios, CRFs, and study areas were applied. In general, without considering population change, our finding of increasing ozone-related mortality in 104 Chinese cities under
RCP8.5 from 2013–2015 to 2053–2055 (10.7%) agrees with the 2005–2030 increase (approximately 20%) projected under a current legislation scenario in eastern China reported by a
recent study [17]. We found more ozone-related deaths under RCP8.5 and fewer deaths under
RCP4.5 in China in 2050 than in 2010, which is consistent with findings for East Asia in previous global studies [15,54].
Few studies have assessed the impacts of climate change on ozone-related cause-specific
mortality, especially mortality from cardiovascular diseases. Constrained by available CRFs,
previous studies focused on either respiratory mortality from long-term exposure [15,16] or
total mortality from short-term exposure [9,10,13,17]. In this study, future ozone-related acute
excess mortality from cardiovascular diseases was 5–8 times greater than that from respiratory
diseases (Fig 2D). This was mainly due to the higher proportion of baseline cardiovascular
mortality and the stronger associations of short-term ozone exposure with cardiovascular
mortality [46]. In 2013, cardiovascular disease accounted for 44.6% of total non-accidental
mortality in China, whereas respiratory disease only accounted for 12.8% [24]. Consistent with
previous epidemiological studies [55–57], the ozone-related mortality risk estimates we
obtained from a previous publication were larger for cardiovascular disease than for respiratory disease [46]. Our findings suggest that future interventions to reduce the burden of cardiovascular disease should also incorporate measures to reduce climate-change-induced
ambient ozone pollution.
Future ozone-related acute excess mortality will be substantially amplified by an aging population in the 104 Chinese cities studied (Fig 3). Due to the higher baseline mortality rates in
older people (Table 1) and the vulnerability of older people to ambient ozone pollution
[22,23], population aging is projected to contribute 187%–324% and 270%–467% ozonerelated acute excess mortality across the 5 SSPs under RCP4.5 and RCP8.5, respectively. The
impact of population aging under SSP1 and SSP5 could offset the reduced deaths due to
decreasing age-group-specific baseline mortality rates and lower ozone concentrations in
2053–2055 under RCP4.5. Although population size slightly decreases in 2050 relative to 2010
(Fig 1C), the steep increases in the elderly population lead to increasing ozone-related acute
excess mortality attributable to population change. Our findings indicate that not considering
population aging (i.e., using age-group-specific CRFs and baseline mortality rates) may greatly
underestimate future ozone-related acute excess mortality.
The seasonal variations in ozone-related acute excess mortality burdens reflect changes in
seasonal ozone concentrations (Fig 4A). Interestingly, a projected reversal of the ozone seasonal cycle (from a summer maximum to a winter and early spring maximum) under RCP8.5
in the 21st century was also found in urban southeastern China [29]. Opposing seasonal ozone
changes (decreasing in summer but increasing in winter) have been identified in the US over a
historical period with decreasing NOx and volatile organic compound emissions (1998–2013)
[58]. A recent study also found decreases in US summer ozone and increases in winter ozone
under both RCP4.5 and RCP8.5, reflecting at least partially less ozone titration by NOx in the
cold season, with low chemical reactivity and declining NOx emissions [59]. A recent study
using a decadal record of satellite observations found that US cities were generally within a
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NOx-saturated regime in winter, thus decreasing NOx emissions and a decreased NOx titration
effect could lead to increased wintertime ozone [60]. Under RCP8.5, the approximate doubling
of global methane abundances yields higher ozone concentrations, particularly during the cold
season, when the ozone lifetime is longer [29]. In this study, we found decreases in warm season ozone and a reversal of ozone seasonal cycle under both RCPs (Fig 4A). This may be due
to declines in NOx emissions in China (S2A Fig), which may largely control the shape of the
ozone seasonal cycle [29]. A warmer climate would enhance the warm season ozone (climate
change penalty); however, the NOx emission reductions under both RCP4.5 and RCP8.5 can
fully offset this climate change penalty, resulting in overall decreases in warm season ozone
[29].
Few studies have evaluated the seasonal variations of acute ozone-related health impacts
under climate change [9,11]. Consistent with our findings, ozone-related mortality projections
were found to decrease during the warm season (May to September) and to increase during
the cold season (October to April) under RCP8.5 in the US for 2057–2059 [9]. In contrast,
most of the projected increases in ozone-related mortality were found in summer months
(April to September) in Europe, when applying a threshold of 35 ppb [11]. The inconsistency
of this finding with ours may be due to the no threshold assumption applied in the present
study, which measures the excess deaths attributable to increases in ozone concentrations
below 35 ppb during the winter season. As there is no clear evidence for the existence of a
threshold for the relationship between short-term ozone exposure and daily mortality
[27,47,48], applying a relatively high concentration threshold would significantly underestimate the health impact of climate change via changes in ambient ozone pollution. Most previous studies only projected ozone-related mortality in the warm season, which we emphasize
might underestimate the adverse health effects of ozone exposure throughout the year [25]. A
recent study found that applying a whole year ozone exposure metric with updated risk estimates led to more than double the estimated global long-term ozone-attributable respiratory
mortality compared with using a warm season metric with lower risk estimates [61]. Chinese
urban populations are still exposed to ambient ozone pollution in cold months, with an average of 181 minutes/day spent outdoors in winter [62]. In winter, urban populations in northeastern China spend only 90 minutes/day outdoors, whereas those in southern China spend
218 minutes/day outdoors [62]. Under a warming climate, outdoor exposure to ozone might
change due to changing time-activity patterns, which could influence the seasonality of ozoneattributed mortality in the future. Moreover, consistent with the nationwide seasonal estimates
applied in this study [46], most previous Chinese studies found that the mortality effects of
short-term ozone exposure were higher in the cold season than in the warm season in Shanghai [63], Suzhou [31,64], Zhengzhou [65], Guangzhou [66,67], the Pearl River Delta [68], and
Jiangsu Province [47]. Thus, future research projecting future ozone-related mortality under a
changing climate in different seasons may be warranted.
Our results are based on a recent reference time period (2013–2015), which was chosen due
to the availability of national measurements of ambient ozone concentrations. Compared with
earlier time periods (e.g., 2000–2002), this reference time period has higher levels of ozone pollution [69] and greenhouse gas emissions [70] in China. Hence the estimates of ozone-related
acute excess mortality under climate and emission change reported here are likely lower than
those one would find using earlier reference time periods. Moreover, our estimates assume
independent effects of ozone and fine particulate matter (PM2.5) on daily mortality as the CRF
estimates we used here were robust after adjustment for co-exposure to PM2.5 in 2-pollutant
time-series models [46]. Previous epidemiological studies also found evidence that PM2.5 is
unlikely to confound the association between short-term ozone exposure and daily mortality
[47,71]. Though focused on China, our findings, taken together with studies conducted in
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other regions [9–11,13] and worldwide [15], provide generally consistent evidence on increasing ozone-related mortality burden attributable to climate change under high emission
scenarios.
To the best of our knowledge, this study is the first to account for population aging through
age-group-specific risk estimates and for declining baseline age-group-specific mortality rates
to understand future ozone-related mortality under alternative scenarios of climate and population change. This is also one of the first studies to apply season-specific risk estimates and
baseline mortality rates to assess future mortality from changes in ambient ozone pollution
attributable to climate change. The future ozone-related mortality burden in 104 Chinese cities
is substantially reduced under RCP4.5, which includes effective emission mitigation strategies
[35]. Our findings indicate that stricter mitigation measures will be needed in China to avoid
the increasing health burden of climate change through poor ozone air quality.
There are several limitations in our study. First, only 1 global chemistry–climate model was
applied to project future ozone concentrations. The choice of climate and air quality models
has been found to dominate the uncertainty (approximately 48% to 97%) in projecting ozonerelated health impacts [15,23]. In a recent multi-model study, future global ozone-attributed
mortality estimates under RCP8.5 were found to be widely spread among models, while the
atmospheric component of GFDL-CM3 produced estimates close to the multi-model averages
[15]. Though 3 ensemble members were used to lessen uncertainty arising from internally generated climate variability to some extent, future multi-model studies (e.g., the Aerosol Chemistry Model Intercomparison Project [72]) will further address the uncertainty arising from
global model projections. Second, the statistical downscaling applied in this study may result
in an additional source of uncertainty irrespective of the nature of the global chemistry–climate model. Third, the effects of changing climate were not separated from the effects of
changing ozone precursor emissions under RCP4.5 and RCP8.5 in this study. Fourth, the categories of age groups were chosen based on a previous nationwide time-series study [46], which
was limited by the sample size of each age group and was unable to report the ozone–mortality
CRFs for customary age groups such as 0–5 years, 6–14 years, and 15–65 years. Hence, ozonerelated acute excess mortality was not estimated separately for children in our study. Children
may spend more time outside playing and exercising, which can increase their vulnerability to
the health impacts of ozone exposure [73]. Further investigation is needed to quantify the
impacts of climate change on children’s health [74]. Fifth, the potential interaction between
ozone and temperature on human health was not considered [64,75]. Finally, due to the scarcity of ozone–mortality CRF cohort studies in China, long-term effects of ozone on mortality
were not included in the present study. Recent cohort studies in the US found that a 10-ppb
increase in long-term ozone exposure is associated with a 1.1% to 2.0% increase in all-cause
mortality [76,77], which is larger than the effect of short-term ozone exposure (e.g., a 0.52%
increase in mortality per 10-ppb increase in ozone concentration in the US [55]). Although
joint assessments of acute and chronic effects of ozone exposure on mortality are scarce, future
investigations with available long-term CRF estimates in China may lead to larger estimated
health impacts of climate change.

Conclusion
Overall, we have shown that the future mortality burden for the Chinese population of shortterm exposure to ambient ozone pollution will increase under plausible scenarios of climate
and emission change and population aging. Population aging contributes substantially to the
future ozone-related acute excess mortality. People with cardiovascular disease may require
more care in a changing climate. Cold season ozone may play a more important role than
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currently recognized in future changes of ozone-related mortality in China. The differences in
the direction and magnitude of future changes in ozone-related mortality attributable to climate and emission change under RCP4.5 and RCP8.5 suggest that climate change mitigation
actions, such as preventing atmospheric methane from doubling, are needed to prevent a rising health burden from exposure to ambient ozone pollution in China.

Disclaimer
The authors are solely responsible for the content of this paper and do not represent the official
view of the EPA.

Supporting information
S1 Fig. Spatial distribution of mean maximum daily 8-hour average (MDA8) ozone concentration (ppb) in China during the period April 27, 2013, to October 31, 2015. A total of
778 national ambient ozone monitoring sites were involved in this study. Note that many sites
overlap due to their proximity.
(TIF)
S2 Fig. Changes of annual anthropogenic emission density used in the GFDL-CM3 model in
China (18˚~48˚ N, 100˚~128˚ E) over 2000–2050 under RCP4.5 and RCP8.5 for (A) nitrogen
oxides (NOx) (Tg N/year), (B) nonmethane volatile organic compounds (VOCs) (Tg C/year),
and (C) carbon monoxide (Tg CO/year).
(TIF)
S3 Fig. Spatial distribution of city-specific changes in annual average daily ozone concentration (ppb) under the RCP4.5 and RCP8.5 scenarios.
(TIF)
S4 Fig. Impact of using coarse resolution (2.0˚ × 2.5˚) ozone projections on city-level
ozone concentration changes and cause-specific excess mortality estimates. (A) Difference
between mean ozone changes in 104 Chinese cities at coarse and fine resolution (0.25 × 0.25˚).
The horizontal line within each box represents the median concentration among 104 cities, the
lower and upper boundaries of the box indicate the 25th and 75th percentiles, and the ends of
the whisker lines indicate the maximum and minimum concentrations within 1.5 times the
interquartile range from the upper and lower box boundaries. (B) Future changes (%) in
ozone-related mortality by cause of death (cardiovascular, respiratory, and other causes of
non-accidental deaths) based on coarse resolution ozone projections. RCP4.5 and RCP8.5 represent moderate and high global warming and emission scenarios, respectively. (C) Percent
difference between cause-specific ozone-related acute excess mortality at coarse and fine resolutions. (D) Spatial distribution of percent difference between cause-specific ozone-related
acute excess mortality at coarse and fine resolutions in 104 Chinese cities in 2053–2055 relative
to 2013–2015 under RCP8.5. (E) Same as (D) but under RCP4.5.
(TIF)
S1 Method. The statistical downscaling method: Bias-correction spatial disaggregation
(BCSD).
(PDF)
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